TMSB10 and ovarian carcinoma: To examine the effects of overexpression of Tβ10 on cancer cell viability, subconfluent 2774 ovarian cancer cells were infected with Ad.TERT.LacZ or Ad.TERT.Tβ10 at an MOI of 10, and the MTT-bioassay was performed daily for 6 days.